Fearon E R
Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut.
Adv Intern Med. 1994;39:123-47.
During the past decade, a great deal of progress has been made toward identifying some of the genetic alterations that underlie human cancer development in general, and colorectal cancer in particular. It is now clear that mutations in both oncogenes and tumor suppressor genes have an important role in the process. However, much work lies ahead before a complete understanding of the pathogenesis of colorectal tumors will be obtained. It seems reasonable to predict that additional oncogenes and tumor suppressor genes with important roles in colorectal cancer remain to be identified. Characterization of the function of these genes in normal and neoplastic cell growth will be crucial. Unfortunately, we know little about the functions of the oncogenes and tumor suppressor genes already implicated in colorectal cancer. Undoubtedly, it will be crucial to understand the role of environmental and dietary influences on the nature and rate of mutations in colorectal tumors. Little is known about the relative significance of each of the various inherited and somatic mutations to the cancer phenotype. Moreover, although some preliminary studies have suggested possible clinical applications of the genetic studies to improved diagnosis and management of patients at risk of and harboring colorectal cancer, the scope and significance of the observations thus far are limited. Nevertheless, an optimistic view is that future molecular genetic studies not only will yield insights into the molecular basis of colorectal cancer, but also will improve the care of patients with colorectal tumors.
在过去十年中,在确定一些导致人类癌症发生,尤其是结直肠癌发生的基因改变方面已经取得了很大进展。现在很清楚,癌基因和肿瘤抑制基因的突变在这个过程中都起着重要作用。然而,在完全了解结直肠肿瘤的发病机制之前,还有很多工作要做。可以合理预测,在结直肠癌中起重要作用的其他癌基因和肿瘤抑制基因仍有待发现。了解这些基因在正常和肿瘤细胞生长中的功能将至关重要。不幸的是,我们对已经与结直肠癌相关的癌基因和肿瘤抑制基因的功能知之甚少。毫无疑问,了解环境和饮食对结直肠肿瘤突变性质和发生率的影响作用至关重要。对于各种遗传和体细胞突变对癌症表型的相对重要性,我们所知甚少。此外,尽管一些初步研究表明基因研究在改善对有患结直肠癌风险和患有结直肠癌患者的诊断和管理方面可能有临床应用,但迄今为止这些观察结果的范围和意义有限。然而,乐观的看法是,未来的分子遗传学研究不仅将深入了解结直肠癌的分子基础,还将改善对结直肠肿瘤患者的治疗。